An oligonucleotide mixture for improved detection of human papillomavirus genotypes
Cervical cancer (cancer of the uterine cervix) is the second most common cancer among women worldwide with about 470,000 newly diagnosed cases and almost 250,000 deaths every year. The predominant cause for cervical cancer is infection of the cervix with human papillomavirus (HPV), particularly with high-risk HPV genotypes.
The identification of specific HPV genotypes is important, as various HPV genotypes and multiple infections pose different risks to the affected pa-tients. HPV DNA tests are detecting ongoing infections and cervical lesions but their specificity for ab-sence disease is low. In contrast, high viral load was shown to improve the specificity significantly. There is a need for more reliable tests detecting and quantifying different human papillomavirus (HPV) genotypes and, in particular, the high-risk and putative high-risk genotypes.
Further Information: PDF
DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Sea slugs inspire highly stretchable biomedical sensor
USC Viterbi School of Engineering researcher Hangbo Zhao presents findings on highly stretchable and customizable microneedles for application in fields including neuroscience, tissue engineering, and wearable bioelectronics. The revolution in…
Twisting and binding matter waves with photons in a cavity
Precisely measuring the energy states of individual atoms has been a historical challenge for physicists due to atomic recoil. When an atom interacts with a photon, the atom “recoils” in…
Nanotubes, nanoparticles, and antibodies detect tiny amounts of fentanyl
New sensor is six orders of magnitude more sensitive than the next best thing. A research team at Pitt led by Alexander Star, a chemistry professor in the Kenneth P. Dietrich…